GPS News  
INTERN DAILY
Fire ant venom could be used for skin treatments
by Amy Wallace
Washington (UPI) Sep 11, 2017


A new study from Emory and Case Western universities found that compounds from fire ant venom could reduce skin thickening and inflammation in psoriasis.

Psoriasis is an autoimmune skin disease that is treated with topical sterioids that can cause skin thinning and bruising.

Researchers used mouse models of psoriasis to test the compound solenopsin, the main toxic component in fire ant venom, which chemically resemble ceramides, the lipid-like molecules necessary for maintaining the barrier function of skin.

The study, published today in Scientific Reports, showed solenopsin decreased skin thickness from psoriasis 30 percent compared to control groups.

"We believe that solenopsin analogs are contributing to full restoration of the barrier function in the skin," Dr. Jack Arbiser, professor of dermatology at Emory University School of Medicine, said in a press release. "Emollients can soothe the skin in psoriasis, but they are not sufficient for restoration of the barrier."

Researchers created two solenopsin analogs that resemble ceramides but can't degrade into S1P, or sphingosine-1-phosphate, that can convert ceramides into an inflammatory molecule.

Researchers found that the mice treated with solenopsin analogs also had 50 percent fewer immune cells infiltrating the skin and when the compound was applied to immune cells in a culture they decreased the cells' production of the inflammatory signal IL-22 and increased production of anti-inflammatory IL-12.

The study showed that the solenopsin analogs turned down genes that are turned up by current treatments.

"This may be compensatory and a mechanism of resistance to anti-psoriasis therapy, and it suggests that the solenopsin compounds could be used in combination with existing approaches," Arbiser said.

INTERN DAILY
Lizard venom could yield blood clot treatment breakthrough
Washington (UPI) Aug 8, 2017
Scientists have created a variety of medicines using compounds discovered in the venoms of snakes, frogs, snails, jellyfish and other animals. New research suggests lizard venoms could serve as an untapped source of medicinal compounds. Specifically, scientists at the University of Queensland believe lizard venoms could yield new treatments for blood clots. Research into lizard v ... read more

Related Links
Hospital and Medical News at InternDaily.com


Thanks for being here;
We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain.

With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords.

Our news coverage takes time and effort to publish 365 days a year.

If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor
$5 Billed Once


credit card or paypal
SpaceDaily Monthly Supporter
$5 Billed Monthly


paypal only


Comment using your Disqus, Facebook, Google or Twitter login.

Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle

INTERN DAILY
Foodies cheesed off as China says 'non' to France's finest

EU chamber urges China to lift cheese ban

Parched Jordan starts growing vegetables in

Research finds roots use chemical 'photos' to coordinate growth

INTERN DAILY
Trump blocks Chinese acquisition of US semiconductor firm

Toshiba: Japan's faded titan selling the family silver

Flip-flop qubits: Radical new quantum computing design invented

Researchers validate UV light's use in improving semiconductors

INTERN DAILY
Typhoon offered as F-16 replacement for Belgium

Air Traffic "Win-Win" Wins NASA Software of the Year

Boeing tips China to need $1.1 tn new planes over next 20 years

Airbus Perlan Mission II Soars Into History, Sets New World Record for Glider Altitude

INTERN DAILY
VW recalls 4.86 million vehicles in China over airbag concerns

Waymo suit against Uber on road to trial

Rickshaws to jump start India's all-electric drive

Wax on, melt off: Roads that deice themselves during winter storms

INTERN DAILY
China bank loans rebound in August

Europe must seize Brexit 'window of opportunity', says Juncker

Top Chinese bitcoin exchange shuts down

France slams Silicon Valley for skirting tax in Europe

INTERN DAILY
Poland accuses EU's top court of bias in primeval forest case

Chocolate industry driving deforestation of Ivory Coast: report

Hidden Inca treasure: Remarkable new tree genus discovered in the Andes

Deforestation long overlooked as contributor to climate change

INTERN DAILY
Boeing to Design and Build Seven Medium Earth Orbit Satellites for SES

Airbus to reshape Earth observation market with its Pleiades Neo constellation

Ball Aerospace Delivers the JPSS-1 Weather Satellite to Launch Site

Ship exhaust helps grow bigger ocean thunderstorms

INTERN DAILY
'Nano-hashtags' could provide definite proof of Majorana particles

UMass Amherst environmental chemist flashes warning light on new nanoparticle

A more complete picture of the nano world

What the world's tiniest 'monster truck' reveals









The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.